2020
Uveal melanoma - testing of abnormalities of chromosome 3 and 8 in the Czech Republic
MATUŠKOVÁ, Veronika; Pavla HORŇÁČKOVÁ; Radoslava UHMANNOVÁ; Lenka ZLÁMALÍKOVÁ; Květoslava LIŠKOVÁ et. al.Základní údaje
Originální název
Uveal melanoma - testing of abnormalities of chromosome 3 and 8 in the Czech Republic
Autoři
MATUŠKOVÁ, Veronika (203 Česká republika, garant, domácí); Pavla HORŇÁČKOVÁ (203 Česká republika, domácí); Radoslava UHMANNOVÁ (203 Česká republika); Lenka ZLÁMALÍKOVÁ (203 Česká republika, domácí); Květoslava LIŠKOVÁ (203 Česká republika, domácí); Michal UHER (203 Česká republika, domácí) a Eva VLKOVÁ (203 Česká republika, domácí)
Vydání
Biomedical Papers, Olomouc, Univerzita Palackého v Olomouci, 2020, 1213-8118
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30207 Ophthalmology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.245
Kód RIV
RIV/00216224:14110/20:00117059
Organizační jednotka
Lékařská fakulta
UT WoS
000604951200008
EID Scopus
2-s2.0-85097777757
Klíčová slova anglicky
uveal melanoma; chromosome 3; chromosome 8; CISH; FISH; progression-free survival
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2021 09:55, Mgr. Tereza Miškechová
Anotace
V originále
Aim: The aim of this cytogenetic study is to confirm the significance of chromosome 3 loss (monosomy 3) and of the gain of chromosome 8 as prognostic markers in histopathological samples of enucleated eyes with uveal melanoma in the Czech population. Methods: This is a retrospective study of 52 enucleated eyes. Chromosome 3 and 8 status were tested by CISH, and in a few samples FISH was used. The correlation between monosomy 3 and gain of chromosome 8 and clinical features (histopathological type, size of the tumour) were evaluated. A follow up for the detection of metastases was conducted in all patients. The statistical significance of chromosomal abnormalities as a prognostic factor for the development of metastases was calculated. Results: There were 52 patients, 27 men (51.9%) and 25 women (48.1%) enrolled in our study group. The mean age was 63 ± 14 years. Loss of the one copy of chromosome 3 (monosomy 3) was detected in 26 (50.0%) patients, monosomy 8 was present in 34.6% of patients with monosomy 3. After 5 years there were no metastases in 82% of patients without monosomy 3 as opposed to 40% of patients with monosomy 3. We confirmed a statistically significant association between progression free survival (PFS) and the presence of monosomy 3 (P=0.017). The association between PFS and gain of chromosome 8 was significant as well (0.010). Conclusions: Our data showed the association of progression-free survival with the presence of monosomy 3 in uveal melanomas. We provided a good prognostic value of monosomy 3 in uveal melanoma.